Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 30, 2015 12:15 AM ET

Biotechnology

Company Overview of Bio-Cancer Treatment International Ltd.

Company Overview

Bio-Cancer Treatment International, Ltd. operates as a biotech company in Hong Kong. It develops BCT-100, an anti-cancer drug candidate, which is a recombinant human enzyme for the treatment of cancers that are dependent on arginine for growth. The company also develops chemical synthetic technology to produce polyethylene glycol; and mSPA-PEG, a bio-polymer used in the production of BCT-100 and other protein therapeutics. It has strategic partnerships with Morningside Asia and Kinexum. The company was founded in 2001 and is based in Shatin, Hong Kong.

Bio-Informatics Centre

Hong Kong Science Park

2 Science Park West Avenue

Room 511-513, 5/F

Shatin,  

Hong Kong

Founded in 2001

Phone:

852 2521 1566

Fax:

852 2521 1560

Key Executives for Bio-Cancer Treatment International Ltd.

Chief Executive Officer and Member of The Scientific Advisory Board
Chief Financial Officer
Executive Director
Age: 68
Executive Director
Age: 63
Chief Scientific Officer of PEG Division and Chief Marketing Officer of PEG Division
Compensation as of Fiscal Year 2015.

Bio-Cancer Treatment International Ltd. Key Developments

Bio-Cancer Treatment International Ltd. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 04:30 PM

Bio-Cancer Treatment International Ltd. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 04:30 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Paul N.M. Cheng, Chief Executive Officer and Member of The Scientific Advisory Board.

Bio-Cancer Treatment International Ltd. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 07:30 AM

Bio-Cancer Treatment International Ltd. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 07:30 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Paul N.M. Cheng, Chief Executive Officer and Member of The Scientific Advisory Board.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Bio-Cancer Treatment International Ltd., please visit www.bio-cancer.org. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.